For Cardioexplorer
 

           


Cardioexplorer wins Swiss Biolabs Award 2018

Heart disease is the leading cause of death. So far there was no simple test for detection of life-threatening constrictions of the heart arteries. Cardioexplorer is a simple and non-invasive Artificial Intelligence based lab test which provides a safe risk assessment of current coronary heart disease. The test provides higher sensitivity / specificity than the stress ECG. 

Out of seven finalists, Exploris has won the Swiss Biolabs Challenge 2018.The jury consisted of Universities (University Hospital Basel, School of Life sciences Biotechnet Switzerland), industry partners (Sensile Medical, Roche Diagnostics, Omya International AG, Ava Science, Bühlmann Laboratories) and  Associations (Swiss Biolabs Association, Economic Development Agency Olten, Basel Area).

 




Cardioexplorer wins 2. Prize 

Cardioexplorer is the first evidence based AI driven Cardiotest which detects narrowing in heart arteries (cause of heart infarction) with higher accuracy than many standard procedures. The test has been validated in three clinical studies in more than 2000 patients.

 



IFAS exhibition team: Peter Ruff, Kimberly Graf, Dr. Michael Failer




 



Start Summit St. Gallen 2019


Keynote: AI based diagnostics - are the doctors ready? 


Followed by Cardioexplorer presentation.




Peter Ruff 





Cardioexplorer at the Trend Tage Gesundheit Lucerne 2019


Startup Expo




Kimberly Graf and Michael Failer


Panel at Chamber of commerce Finnland - Switzerland 2019 

Carmen Frankhauser, Peter Ruff and Tommy Mäkynen discussing entrepreneurship in Switzerland. Finnlands health system is ahead concerning digitalization. Interesting for health-care startups with innovative solutions.